Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VIYASH SCIENTIFIC LIMITED Call Transcript 2025

Feb 6, 2025

62287_rns_2025-02-06_b75929dd-eee0-4f0b-8928-2bcdb4e46c6e.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [144 x 40] intentionally omitted <==

Proven Ability In Life Sciences

February 06, 2025

To,

BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (East), Mumbai – 400 001 Mumbai – 400 051 Scrip code: 512529 Symbol: SEQUENT

Subject: Intimation of Conference call

Dear Sir/ Madam,

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has scheduled a conference call with the Analysts/Investors on Thursday, February 13, 2025, at 9.00 a.m. (I.S.T.) to discuss its Q3FY25 financial results. The Conference call details are enclosed herewith.

You are requested to take the same on record.

Yours faithfully,

For Sequent Scientific Limited

Vora Digitally signed by Yoshita Vora Yoshita Susmit Date: 2025.02.06 Susmit 18:45:26 +05'30'

Yoshita Vora Company Secretary & Compliance Officer Encl.: A/a

SeQuent Scientific Limited

Registered Office: 301, 3[rd] Floor, Dosti Pinnacle, Plot No. E7, Road No. 22, Wagle Industrial Estate, Thane (W), Mumbai - 400604, Maharashtra, India Tel No.: +91-22-4111-4777 I CIN: L99999MH1985PLC036685 Website : http://www.sequent.in I Email Id : [email protected]

==> picture [421 x 506] intentionally omitted <==

==> picture [161 x 40] intentionally omitted <==

SeQuent Q3FY25

Earnings Conference Call 13[th] Feb 2025, 9:00AM

Speakers

Mr. Rajaram Narayanan, MD & CEO, Sequent Scientific Dr. Hari Babu Bodepudi, WTD & CEO, Viyash Lifesciences Mr. Saurav Bhala, Chief Financial Officer, Sequent Scientific Mr. Ramakant Singani, Chief Financial Officer, Viyash Lifesciences

Dial in For SeQuent Q3FY25 Conference call, Details: 13th Feb 2025, Time: 9:00 AM +91 22 6280 1263 Universal +91 22 7115 8213 Access DiamondPass (for early Click here registration)